Asher Bio

Asher BioWe build better immunotherapies

Asher Bio develops precisely targeted immunotherapies for cancer and other diseases. Our cis-targeting platform enables selective activation of specific immune cell types, addressing the limitations of pleiotropic immunotherapies. Learn more.

Asher Bio screenshot

Asher Bio

Asher Bio is pioneering a new approach to targeted immunotherapy, focusing on enhancing efficacy and minimizing side effects. Asher Bio's technologies are revolutionary because they precisely activate only the desired immune cell types, ensuring the desired therapeutic response without impacting other cells.

Product Highlights

  • Feature 1: Asher Bio's technology precisely activates only the desired immune cell types, ensuring the desired therapeutic response without impacting other cells.
  • Feature 2: Asher Bio's technologies enhance efficacy and minimize side effects.
  • Feature 3: Asher Bio's technologies are revolutionary because they precisely activate only the desired immune cell types.

Use Cases

  • Use case 1: Asher Bio's technologies are being used to treat a variety of diseases, including cancer and autoimmune diseases.
  • Use case 2: Asher Bio's technologies are improving patient health and reducing disease risk.
  • Use case 3: Asher Bio's technologies are providing new hope in medicine for the treatment of difficult diseases.

Target Audience

Asher Bio's technologies are aimed at improving the health of patients suffering from a variety of diseases, including cancer and autoimmune diseases.

Weekly Top 10 Products